Roche Diagnostics has received FDA 510(k) clearance for the CoaguChek XS Pro system, a new point-of-care anticoagulation monitor with a built-in bar code reader that can automatically scan and capture operator and patient identification information.
According to Roche, the CoaguChek’s bar code reader works in conjunction with the RALS-Plus information management system to help healthcare professionals save time and prevent errors that could occur from manually entering the information for PT/INR (blood clotting time) testing with patients on warfarin therapy.
The new member of the CoaguChek XS family of meters, the CoaguChek XS Pro system requires a small sample of blood only 8 microliters and provides test results in about one minute. It uses built-in quality controls and offers the option to run two levels of additional liquid controls.
Roche said that the meter can store up to 1000 patient results and 500 optional liquid quality control results, and the operator has the option to enter comments related to either type of result.
The CoaguChek XS Pro system also offers extensive connectivity and data management capabilities by communicating via its optional handheld base unit with the RALS-Plus information management system.
The connectivity enables several reporting and device management features, including operator and QC lockout, operator and patient list management and PT/INR and QC test comment management. The features can help hospital staff streamline the regulatory compliance documentation process, capture reimbursable costs and improve their organizational efficiency.
Tim Huston, director of marketing, professional diagnostics at Roche Diagnostics, said: “The addition of the CoaguChek XS Pro system to the CoaguChek family of products expands the options that healthcare providers have for PT/INR testing at the point of care. The bar code reader functionality, in particular, can help them ensure patient safety and simplify regulatory compliance, making it easier to manage an anticoagulation clinic.”